CS222779A2 - Zpusob pripravy n heterocyklyl 4 piperidinaminu - Google Patents
Zpusob pripravy n heterocyklyl 4 piperidinaminuInfo
- Publication number
- CS222779A2 CS222779A2 CS792227A CS222779A CS222779A2 CS 222779 A2 CS222779 A2 CS 222779A2 CS 792227 A CS792227 A CS 792227A CS 222779 A CS222779 A CS 222779A CS 222779 A2 CS222779 A2 CS 222779A2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- piperidinaminu
- heterocyklyl
- zpusob pripravy
- pripravy
- zpusob
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89253478A | 1978-04-03 | 1978-04-03 | |
| US06/002,276 US4219559A (en) | 1979-01-10 | 1979-01-10 | N-Heterocyclyl-4-piperidinamines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS222779A2 true CS222779A2 (en) | 1987-03-12 |
| CS256358B2 CS256358B2 (en) | 1988-04-15 |
Family
ID=26670178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS792227A CS256358B2 (en) | 1978-04-03 | 1979-04-02 | Method of n-heterocyclyl-4-piperidinamines preparation |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0005318B1 (cs) |
| JP (2) | JPS54151982A (cs) |
| AT (1) | AT373887B (cs) |
| AU (1) | AU523352B2 (cs) |
| BG (1) | BG38164A3 (cs) |
| CA (1) | CA1140119A (cs) |
| CS (1) | CS256358B2 (cs) |
| CY (1) | CY1250A (cs) |
| DE (1) | DE2961740D1 (cs) |
| DK (1) | DK169325B1 (cs) |
| EG (1) | EG13913A (cs) |
| ES (1) | ES479206A1 (cs) |
| FI (1) | FI64801C (cs) |
| GR (1) | GR64907B (cs) |
| HK (1) | HK3184A (cs) |
| HU (1) | HU182965B (cs) |
| IE (1) | IE47818B1 (cs) |
| IL (1) | IL56992A (cs) |
| MY (1) | MY8500046A (cs) |
| NO (2) | NO154058C (cs) |
| NZ (1) | NZ189978A (cs) |
| PH (1) | PH15877A (cs) |
| PL (1) | PL123380B1 (cs) |
| PT (1) | PT69429A (cs) |
| RO (1) | RO79320A (cs) |
| SG (1) | SG29883G (cs) |
| SU (1) | SU1056902A3 (cs) |
| YU (2) | YU42484B (cs) |
| ZA (1) | ZA791557B (cs) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA19091A1 (fr) * | 1980-03-10 | 1981-10-01 | Janssen Pharmaceutica Nv | Nouveaux derives de i-(4-aryl-cyclohexyl)piperidine . |
| US4556660A (en) * | 1982-07-12 | 1985-12-03 | Janssen Pharmaceutica N.V. | N-(Bicyclic heterocyclyl)-4-piperidinamines |
| IN156065B (cs) * | 1982-07-12 | 1985-05-04 | Janssen Pharmaceutica Nv | |
| US4634704A (en) * | 1983-10-06 | 1987-01-06 | Janssen Pharmaceutica, N.V. | Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines |
| DE3484096D1 (de) * | 1983-11-30 | 1991-03-14 | Janssen Pharmaceutica Nv | Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine. |
| PL144514B1 (en) * | 1984-01-09 | 1988-06-30 | Janssen Pharmaceutica Nv | Method of obtaining novel derivatives of n-/4-piperidinolo/-2-imidazoloamine |
| KR930005004B1 (ko) * | 1985-04-15 | 1993-06-11 | 쟈안센 파아마슈우티카 엔. 부이. | 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법 |
| GB8515934D0 (en) * | 1985-06-24 | 1985-07-24 | Janssen Pharmaceutica Nv | (4-piperidinomethyl and-hetero)purines |
| CA1327579C (en) * | 1986-02-03 | 1994-03-08 | Frans Eduard Janssens | Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines |
| NZ223654A (en) * | 1987-03-09 | 1990-03-27 | Janssen Pharmaceutica Nv | 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions |
| FR2618435B1 (fr) * | 1987-07-23 | 1989-10-27 | Synthelabo | Derives de benzimidazole, leur preparation et leur application en therapeutique |
| US5210091A (en) * | 1991-06-24 | 1993-05-11 | Neurosearch A/S | Imidazole compounds and their use |
| WO1994027973A1 (en) * | 1993-05-20 | 1994-12-08 | Kissei Pharmaceutical Co., Ltd. | 1-(2-benzimidazolyl)-1,5-diazacyclooctane derivative |
| US5547966A (en) * | 1993-10-07 | 1996-08-20 | Bristol-Myers Squibb Company | Aryl urea and related compounds |
| HUP0101048A2 (hu) * | 1998-03-06 | 2001-10-28 | Janssen Pharmaceutica N.V. | Glicin transzport gátló hatású 4,4 bisz[(4-fluorfenil)butil]-1-(piperazinil és piperidinil)-származékok és gyógyászati alkalmazásuk |
| KR100731271B1 (ko) | 1999-06-28 | 2007-06-21 | 얀센 파마슈티카 엔.브이. | 호흡기 신시티움 바이러스 복제 억제제 |
| DE60008382T2 (de) * | 1999-06-28 | 2004-12-02 | Janssen Pharmaceutica N.V. | Respiratorisches syncytialvirus replikation inhibitoren |
| HK1046141B (zh) | 1999-06-28 | 2006-09-22 | 詹森药业有限公司 | 呼吸系统的合胞体病毒复制抑制剂 |
| RU2398765C1 (ru) | 2000-03-06 | 2010-09-10 | Акадиа Фармасьютикалз, Инк. | Азациклические соединения для применения при лечении опосредованных серотонином заболеваний |
| EP1363901A4 (en) | 2001-02-02 | 2005-08-31 | Teva Pharma | PROCESS FOR PREPARING SUBSTITUTED 2- (2-PYRIDYLMETHYL) SULFINYL-1H-BENZIMIDAZOLENE |
| ATE466014T1 (de) | 2001-12-28 | 2010-05-15 | Acadia Pharm Inc | Spiroazacyclische verbindungen als monoaminrezeptormodulatoren |
| EP2316468A1 (en) | 2002-02-22 | 2011-05-04 | Shire LLC | Delivery system and methods for protecting and administering dextroamphetamine |
| CA2490397A1 (en) | 2002-06-24 | 2003-12-31 | Acadia Pharmaceuticals Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
| US7253186B2 (en) | 2002-06-24 | 2007-08-07 | Carl-Magnus Andersson | N-substituted piperidine derivatives as serotonin receptor agents |
| US7538222B2 (en) | 2002-06-24 | 2009-05-26 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
| SI2009000T1 (sl) | 2003-01-16 | 2011-09-30 | Acadia Pharm Inc | Selektivni serotoninski 2A/2C receptorski inverzni agonisti kot terapevtiki za nevrodegenerativne bolezni |
| EP1697347B1 (en) | 2003-12-18 | 2011-02-23 | Tibotec Pharmaceuticals | 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| ATE501135T1 (de) * | 2003-12-18 | 2011-03-15 | Tibotec Pharm Ltd | Piperidinamino-benzimidazol-derivate al respiratorisches syncytialvirus replikation inhibitoren |
| AU2004298457B2 (en) | 2003-12-18 | 2010-05-27 | Tibotec Pharmaceuticals Ltd. | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| US20050261278A1 (en) | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
| US7820695B2 (en) | 2004-05-21 | 2010-10-26 | Acadia Pharmaceuticals, Inc. | Selective serotonin receptor inverse agonists as therapeutics for disease |
| US7790899B2 (en) | 2004-09-27 | 2010-09-07 | Acadia Pharmaceuticals, Inc. | Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| EP2289879B1 (en) | 2004-09-27 | 2014-11-12 | Acadia Pharmaceuticals Inc. | Synthesis of a crystalline form of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide tartrate salt |
| PL2134330T3 (pl) | 2007-03-19 | 2013-10-31 | Acadia Pharm Inc | Kombinacje odwrotnych agonistów i antagonistów 5-HT2A z antypsychotykami |
| JP6850282B2 (ja) | 2015-07-20 | 2021-03-31 | アカディア ファーマシューティカルズ インコーポレーテッド | Ｎ−（４−フルオロベンジル）−ｎ−（１−メチルピペリジン−４−イル）−ｎ’−（４−（２−メチルプロピルオキシ）フェニルメチル）カルバミドならびにその酒石酸塩および多形形態ｃを調製する方法 |
| US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
| WO2017165635A1 (en) | 2016-03-25 | 2017-09-28 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome p450 modulators |
| US11464768B2 (en) | 2016-12-20 | 2022-10-11 | Acadia Pharmaceuticals Inc. | Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis |
| EP3615028A1 (en) | 2017-04-28 | 2020-03-04 | Acadia Pharmaceuticals Inc. | Pimavanserin for treating impulse control disorder |
| WO2019046167A1 (en) | 2017-08-30 | 2019-03-07 | Acadia Pharmaceuticals Inc. | PIMAVANSERIN FORMULATIONS |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2857391A (en) * | 1955-04-15 | 1958-10-21 | Merck & Co Inc | Aminomethylbenzimidazoles |
| US2971005A (en) * | 1958-10-17 | 1961-02-07 | Merck & Co Inc | Nu-substituted derivatives of 2-benzylaminobenzimidazoles |
| BE788065A (fr) * | 1971-08-26 | 1973-02-26 | Degussa | Nouvelles aza-benzimidazoles et procede pour leur preparation |
-
1979
- 1979-03-19 CA CA000323763A patent/CA1140119A/en not_active Expired
- 1979-03-21 AU AU45296/79A patent/AU523352B2/en not_active Expired
- 1979-03-23 NZ NZ189978A patent/NZ189978A/en unknown
- 1979-03-29 DK DK129879A patent/DK169325B1/da not_active IP Right Cessation
- 1979-03-29 GR GR58721A patent/GR64907B/el unknown
- 1979-03-30 EP EP79300525A patent/EP0005318B1/en not_active Expired
- 1979-03-30 CY CY1250A patent/CY1250A/xx unknown
- 1979-03-30 RO RO7997082A patent/RO79320A/ro unknown
- 1979-03-30 DE DE7979300525T patent/DE2961740D1/de not_active Expired
- 1979-04-01 EG EG200/79A patent/EG13913A/xx active
- 1979-04-02 FI FI791084A patent/FI64801C/fi not_active IP Right Cessation
- 1979-04-02 JP JP3844779A patent/JPS54151982A/ja active Granted
- 1979-04-02 AT AT0242579A patent/AT373887B/de not_active IP Right Cessation
- 1979-04-02 IL IL56992A patent/IL56992A/xx unknown
- 1979-04-02 NO NO791097A patent/NO154058C/no unknown
- 1979-04-02 ES ES479206A patent/ES479206A1/es not_active Expired
- 1979-04-02 CS CS792227A patent/CS256358B2/cs unknown
- 1979-04-02 ZA ZA791557A patent/ZA791557B/xx unknown
- 1979-04-03 SU SU792747000A patent/SU1056902A3/ru active
- 1979-04-03 YU YU784/79A patent/YU42484B/xx unknown
- 1979-04-03 BG BG043114A patent/BG38164A3/xx unknown
- 1979-04-03 HU HU79JA841A patent/HU182965B/hu unknown
- 1979-04-03 PT PT69429A patent/PT69429A/pt unknown
- 1979-04-03 PL PL1979214648A patent/PL123380B1/pl unknown
- 1979-04-03 PH PH22344A patent/PH15877A/en unknown
- 1979-08-08 IE IE676/79A patent/IE47818B1/en not_active IP Right Cessation
-
1983
- 1983-03-02 YU YU502/83A patent/YU43158B/xx unknown
- 1983-05-26 SG SG298/83A patent/SG29883G/en unknown
-
1984
- 1984-01-12 HK HK31/84A patent/HK3184A/en not_active IP Right Cessation
- 1984-06-25 NO NO842563A patent/NO154090C/no unknown
-
1985
- 1985-12-30 MY MY46/85A patent/MY8500046A/xx unknown
-
1988
- 1988-06-14 JP JP63144898A patent/JPH01117880A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS254979A2 (en) | Zpusob vyroby 2 pyridylmethylsulfinylbenzimidazolu | |
| CS222779A2 (en) | Zpusob pripravy n heterocyklyl 4 piperidinaminu | |
| JPS5549395A (en) | 55substituted 11*2**deoxyy2**substitutedd betaaddarabinofuranosyl*pyrimidinenucleoside | |
| CS520079A2 (en) | Nosna soustava snimaci hlavice | |
| JPS554364A (en) | 2**deoxyy55*22halogenovinyl**uridins | |
| JPS55129279A (en) | 2*33dihydrobenzopyrann44carboxyimidates | |
| BG27580A1 (en) | Two- poled pelvis- thight articulation- set | |
| CS74479A2 (en) | Omezovac nadmerne proudove vodivosti televizni reprodukcni obrazovky | |
| CS333379A2 (en) | Upinaci zarizeni | |
| JPS5573657A (en) | 1*2*4*55tetraalkyll44arylpiperidines | |
| CS615079A2 (en) | Zpusob vyroby inhibitoru enzymu | |
| CS613879A2 (en) | Zpusob vyroby fenylchinolizidinu | |
| CS290179A2 (en) | Plynova vybojka | |
| JPS54122280A (en) | 2*66dimethyll3*55dimethoxycarbonyll44 *00difluoromethoxyphenyl**1*44dihydropyridine | |
| JPS5573674A (en) | 3*33substituted spiroo1*2*44benzothiadiazine | |
| JPS54145686A (en) | Antiiarthritic 2*4*66tris*substituteddamino* sstriazines | |
| JPS5522661A (en) | 1*66dimethyll3*44dimethyllddmannitol | |
| CS771179A2 (en) | Zpusob vyroby selektivne acylovaneho n chraneneho derivatu aminoglykosidoveho antibiotika | |
| CS686179A2 (en) | Zpusob vyroby fenylchinolizidinu | |
| JPS54135762A (en) | 4*66dihalosteroids | |
| JPS5589262A (en) | 16*166dimethyll177oxaprostaglandins | |
| GB2020650B (en) | 5-imino-4-hydroxymethyl-3-isoxazolidones having antitumouractivity | |
| CS839779A2 (en) | Zpusob vyroby benzimidazol-karbamatu | |
| CS556679A2 (en) | Zpusob vyroby derivatu chlorambucilu | |
| IE781973L (en) | 11 ó-dialkylamino-androstanes |